Skip to main content
Erschienen in: European Journal of Pediatrics 8/2005

01.08.2005 | Original Paper

Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene

verfasst von: Christian Balmer, Diana Ballhausen, Nils U. Bosshard, Beat Steinmann, Eugen Boltshauser, Urs Bauersfeld, Andrea Superti-Furga

Erschienen in: European Journal of Pediatrics | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Abstract

A boy presented at age 2.5 years with mild left ventricular hypertrophy and mild myopathy. Hypertrophic cardiomyopathy progressed relentlessly, leading to death at age 16 years shortly before planned heart transplantation. During the course of the disease, his mother developed severe dilated cardiomyopathy and died of its complications at 46 years of age. The combination of myopathy and cardiomyopathy, the biochemical and electron microscopy findings in a muscle biopsy, and the pedigree suggested Danon disease (MIM 300257), an X-linked lysosomal storage disorder caused by deficiency of lysosome-associated membrane protein-2 (LAMP2). The diagnosis was confirmed by the identification of a novel mutation, G138A, in the LAMP2gene, leading to the premature stop codon W46X. Conclusion:Early diagnosis of Danon disease is important for genetic counselling and timely cardiac transplantation, the only effective therapeutic option.
Literatur
1.
Zurück zum Zitat Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB, Walter M, Li GH, Burgon PG, Maguire CT, Stapleton D, Schmitt JP, Guo XX, Pizard A, Kupershmidt S, Roden DM, Berul CI, Seidman CE, Sedman JG (2003) Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 107: 2850–2856CrossRefPubMed Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB, Walter M, Li GH, Burgon PG, Maguire CT, Stapleton D, Schmitt JP, Guo XX, Pizard A, Kupershmidt S, Roden DM, Berul CI, Seidman CE, Sedman JG (2003) Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 107: 2850–2856CrossRefPubMed
2.
Zurück zum Zitat Baum H, Dodgson KS, Spencer B (1959) The assay of arylsulphatases A and B in human urine. Clin Chim Acta 4: 453–455CrossRefPubMed Baum H, Dodgson KS, Spencer B (1959) The assay of arylsulphatases A and B in human urine. Clin Chim Acta 4: 453–455CrossRefPubMed
3.
Zurück zum Zitat Bergia B, Sybers HD, Butler IJ (1986) Familial lethal cardiomyopathy with mental retardation and scapuloperoneal muscle dystrophy. J Neurol Neurosurg Psychiatry 49: 1423–1426PubMed Bergia B, Sybers HD, Butler IJ (1986) Familial lethal cardiomyopathy with mental retardation and scapuloperoneal muscle dystrophy. J Neurol Neurosurg Psychiatry 49: 1423–1426PubMed
4.
Zurück zum Zitat Beutler E (1975) Red cell metabolism. Grune and Stratton, New York, pp 42–45 Beutler E (1975) Red cell metabolism. Grune and Stratton, New York, pp 42–45
5.
Zurück zum Zitat Beutler E, Kuhl W, Matsumoto F, Pangalis G (1976) Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher’s and Fabry’s disease. J Exp Med 143: 975–980CrossRefPubMed Beutler E, Kuhl W, Matsumoto F, Pangalis G (1976) Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher’s and Fabry’s disease. J Exp Med 143: 975–980CrossRefPubMed
6.
Zurück zum Zitat Bru P, Pellissier JF, Gatau-Pelanchon J, Faugère G, de Barsy T, Levy S, Gérard R (1988) Glycogenose lysosomiale cardio-musculaire de l’adulte sans deficit enzymatique connu. Arch Mal Coeur Vaiss 81: 109–114 Bru P, Pellissier JF, Gatau-Pelanchon J, Faugère G, de Barsy T, Levy S, Gérard R (1988) Glycogenose lysosomiale cardio-musculaire de l’adulte sans deficit enzymatique connu. Arch Mal Coeur Vaiss 81: 109–114
7.
Zurück zum Zitat Byrne E, Dennett X, Crotty B, Trounce I, Sands JM, Hawkins R, Hammond J, Anderson S, Haan EA, Pollard A (1986) Dominantly inherited cardioskeletal myopathy with lysosomal glycogen storage and normal acid maltase levels. Brain 109: 523–536PubMed Byrne E, Dennett X, Crotty B, Trounce I, Sands JM, Hawkins R, Hammond J, Anderson S, Haan EA, Pollard A (1986) Dominantly inherited cardioskeletal myopathy with lysosomal glycogen storage and normal acid maltase levels. Brain 109: 523–536PubMed
8.
Zurück zum Zitat Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S, Schliselfeld LH (1981) Lysosomal glycogen storage disease with normal acid maltase. Neurology 31: 51–57PubMed Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S, Schliselfeld LH (1981) Lysosomal glycogen storage disease with normal acid maltase. Neurology 31: 51–57PubMed
9.
Zurück zum Zitat DeBakey ME, Bernowski R (1998) The DeBakey/NASA axial flow ventricular assist device. In: Akutsu T, Koyanagi H (eds) Heart replacement and artificial heart. Springer, Tokyo, pp 407–413 DeBakey ME, Bernowski R (1998) The DeBakey/NASA axial flow ventricular assist device. In: Akutsu T, Koyanagi H (eds) Heart replacement and artificial heart. Springer, Tokyo, pp 407–413
10.
Zurück zum Zitat Dworzak F, Casazza F, Mora M, De Maria R, Gronda E, Baroldi G, Rimoldi M, Morandi L, Cornelio F (1994) Lysosomal glycogen storage with normal acid maltase: a familial study with successful heart transplant. Neuromuscul Disord 4: 243–247CrossRefPubMed Dworzak F, Casazza F, Mora M, De Maria R, Gronda E, Baroldi G, Rimoldi M, Morandi L, Cornelio F (1994) Lysosomal glycogen storage with normal acid maltase: a familial study with successful heart transplant. Neuromuscul Disord 4: 243–247CrossRefPubMed
11.
Zurück zum Zitat Fukuda M (1994) Biogenesis of the lysosomal membrane. Subcell Biochem 22: 199–230PubMed Fukuda M (1994) Biogenesis of the lysosomal membrane. Subcell Biochem 22: 199–230PubMed
12.
Zurück zum Zitat Galjaard H (1980) Genetic metabolic diseases. Early diagnosis and prenatal analysis. Elsevier, Amsterdam, pp 812–828 Galjaard H (1980) Genetic metabolic diseases. Early diagnosis and prenatal analysis. Elsevier, Amsterdam, pp 812–828
13.
Zurück zum Zitat Hart ZH, Servidei S, Peterson PL, Chang CH, DiMauro S (1987) Cardiomyopathy, mental retardation and autophagic vacuolar myopathy. Neurology 37: 1065–1068PubMed Hart ZH, Servidei S, Peterson PL, Chang CH, DiMauro S (1987) Cardiomyopathy, mental retardation and autophagic vacuolar myopathy. Neurology 37: 1065–1068PubMed
14.
Zurück zum Zitat Hers HG (1964) Glycogen storage disease. In: Levine R, Luft R (eds) Advances in metabolic disorders, vol. I. Academic Press, New York London, pp 1–44 Hers HG (1964) Glycogen storage disease. In: Levine R, Luft R (eds) Advances in metabolic disorders, vol. I. Academic Press, New York London, pp 1–44
15.
Zurück zum Zitat Horvath J, Ketelsen UP, Geibel-Zehender A, Boehm N, Olbrich H, Korinthenberg R, Omran H (2003) Identification of a novel LAMP2 mutation responsible for X-chromosomal dominant Danon disease. Neuropediatrics 34: 270–273CrossRefPubMed Horvath J, Ketelsen UP, Geibel-Zehender A, Boehm N, Olbrich H, Korinthenberg R, Omran H (2003) Identification of a novel LAMP2 mutation responsible for X-chromosomal dominant Danon disease. Neuropediatrics 34: 270–273CrossRefPubMed
16.
Zurück zum Zitat Huijing F (1974) Glycogen and enzymes of glycogen metabolism. In: Curtius HC, Roth M (eds) Clinical biochemistry, vol. II. W. de Gruyter, Berlin New York, pp 1208–1235 Huijing F (1974) Glycogen and enzymes of glycogen metabolism. In: Curtius HC, Roth M (eds) Clinical biochemistry, vol. II. W. de Gruyter, Berlin New York, pp 1208–1235
17.
Zurück zum Zitat Krisman CR (1962) A method for the colorimetric estimation of glycogen with iodine. Anal Biochem 4: 17–23CrossRefPubMed Krisman CR (1962) A method for the colorimetric estimation of glycogen with iodine. Anal Biochem 4: 17–23CrossRefPubMed
18.
Zurück zum Zitat Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, Sue CM, Yamamoto A, Murakami N, Shanske S, Byrne E, Bonilla E, Nonaka I, DiMauro S, Hirano M (2000) Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406: 906–910CrossRefPubMed Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, Sue CM, Yamamoto A, Murakami N, Shanske S, Byrne E, Bonilla E, Nonaka I, DiMauro S, Hirano M (2000) Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406: 906–910CrossRefPubMed
19.
Zurück zum Zitat Saftig P, Tanaka Y, Lüllmann-Rauch R, von Figura K (2001) Disease model: LAMP-2 enlightens Danon disease. Trends Mol Med 7: 37–39CrossRefPubMed Saftig P, Tanaka Y, Lüllmann-Rauch R, von Figura K (2001) Disease model: LAMP-2 enlightens Danon disease. Trends Mol Med 7: 37–39CrossRefPubMed
20.
Zurück zum Zitat Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M, Riggs JE, Colomer J, Iturriaga C, Meloni A, Lamperti C, Saitoh S, Byrne E, DiMauro S, Nonaka I, Hirano M, Nishino I (2002) Clinicopathological features of genetically confirmed Danon disease. Neurology 58: 1773–1778PubMed Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M, Riggs JE, Colomer J, Iturriaga C, Meloni A, Lamperti C, Saitoh S, Byrne E, DiMauro S, Nonaka I, Hirano M, Nishino I (2002) Clinicopathological features of genetically confirmed Danon disease. Neurology 58: 1773–1778PubMed
21.
Zurück zum Zitat Tachi N, Tachi M, Sasaki K, Tomita H, Wakai S, Annaka S, Minami R, Tsurui S, Sugie H (1989) Glycogen storage disease with normal acid maltase: skeletal and cardiac muscles. Pediatr Neurol 5: 60–63CrossRefPubMed Tachi N, Tachi M, Sasaki K, Tomita H, Wakai S, Annaka S, Minami R, Tsurui S, Sugie H (1989) Glycogen storage disease with normal acid maltase: skeletal and cardiac muscles. Pediatr Neurol 5: 60–63CrossRefPubMed
22.
Zurück zum Zitat Takahashi M, Yamamoto A, Takano K, Sudo A, Wada T, Goto Y, Nishino I, Saitoh S (2002) Germline mosaicism of a novel mutation in lysosome-associated membrane protein-2 deficiency (Danon disease). Ann Neurol 52: 122–125CrossRefPubMed Takahashi M, Yamamoto A, Takano K, Sudo A, Wada T, Goto Y, Nishino I, Saitoh S (2002) Germline mosaicism of a novel mutation in lysosome-associated membrane protein-2 deficiency (Danon disease). Ann Neurol 52: 122–125CrossRefPubMed
23.
Zurück zum Zitat Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lüllmann-Rauch R, Janssen PM, Blanz J, von Figura K, Saftig P (2000) Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406: 902–906CrossRefPubMed Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lüllmann-Rauch R, Janssen PM, Blanz J, von Figura K, Saftig P (2000) Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406: 902–906CrossRefPubMed
24.
Zurück zum Zitat Tse HF, Shek TW, Tai YT, Lau YK, Ma L (1996) Case report: lysosomal glycogen storage disease with normal acid maltase: an unusual form of hypertrophic cardiomyopathy with rapidly progressive heart failure. Am J Med Sci 312: 182–186CrossRefPubMed Tse HF, Shek TW, Tai YT, Lau YK, Ma L (1996) Case report: lysosomal glycogen storage disease with normal acid maltase: an unusual form of hypertrophic cardiomyopathy with rapidly progressive heart failure. Am J Med Sci 312: 182–186CrossRefPubMed
25.
Zurück zum Zitat Usuki F, Takenega S, Higuchi I, Kashio N, Nakagawa M, Osame M (1994) Morphologic findings in biopsied skeletal muscle and cultured fibroblasts from a female patient with Danon’s disease (lysosomal glycogen storage disease without acid maltase deficiency). J Neurol Sci 127: 54–60CrossRefPubMed Usuki F, Takenega S, Higuchi I, Kashio N, Nakagawa M, Osame M (1994) Morphologic findings in biopsied skeletal muscle and cultured fibroblasts from a female patient with Danon’s disease (lysosomal glycogen storage disease without acid maltase deficiency). J Neurol Sci 127: 54–60CrossRefPubMed
26.
Zurück zum Zitat Verloes A, Massin M, Lombet J, Grattagliano B, Soyeur D, Rigo J, Koulischer L, Van Hoof F (1997) Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form. Am J Med Genet 72: 135–142CrossRefPubMed Verloes A, Massin M, Lombet J, Grattagliano B, Soyeur D, Rigo J, Koulischer L, Van Hoof F (1997) Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form. Am J Med Genet 72: 135–142CrossRefPubMed
Metadaten
Titel
Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene
verfasst von
Christian Balmer
Diana Ballhausen
Nils U. Bosshard
Beat Steinmann
Eugen Boltshauser
Urs Bauersfeld
Andrea Superti-Furga
Publikationsdatum
01.08.2005
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 8/2005
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-005-1678-z

Weitere Artikel der Ausgabe 8/2005

European Journal of Pediatrics 8/2005 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.